<DOC>
	<DOCNO>NCT00580424</DOCNO>
	<brief_summary>We propose prospective cohort study assess effect progesterone contraceptive pill ( minipill ) coagulation parameter know associate risk thrombosis ( blood clot ) woman increase risk form blood clot . We plan recruit woman history venous thromboembolism ( VTE , blood clot vein ) woman history blood test demonstrate increase risk thrombosis desire contraception . Women enrol study undergo phlebotomy ( blood draw ) baseline ( prior start minipill ) , one three month . Stored sample use measure D-dimer , C-reactive protein ( CRP ) , antithrombin ( AT ) , factor VIII , free total protein S , fibrinogen , von Willebrand factor ( vWF ) normalize activate protein C sensitivity ratio ( nAPCsr ) . Both group undergo general physical GYN exam prior enrollment . This exam blood test provide free charge . Patients prescribe minipill completion study advise consult primary care physician hematologist wish continue medication .</brief_summary>
	<brief_title>The Effect Mini-pill Blood Factors Women Increased Risk Forming Blood Clots</brief_title>
	<detailed_description />
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<mesh_term>Norethindrone acetate</mesh_term>
	<criteria>Women history venous thromboembolism ( VTE , blood clot vein ) woman history blood test demonstrate increase risk thrombosis desire contraception . Blood test demonstrate increase risk thrombosis include follow : Hyperhomocysteinemia/MTHFR mutation Prothrombin gene mutation Factor V Leiden heterozygotes Factor V Leiden homozygote , antithrombin III mutation Protein S deficiency Protein C deficiency . Women current anticoagulation therapy Women history oral contraceptive relate thrombotic event Active history cigarette smoking within past 6 month Pregnancy Active lactation Known hypersensitivity progestin Any history malignancy History within last three month surgery plan surgery study period Undiagnosed vaginal bleeding Active liver disease history within last 5 year alcoholism drug abuse . Additionally , woman must great 3 month postpartum two month without contraceptive hormone ( birth control pill ) 6 month without DepoProvera use prior enrollment .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>52 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>